OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of colchicine on mortality in patients with COVID-19 – A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102395-102395
Open Access | Times Cited: 12
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102395-102395
Open Access | Times Cited: 12
Showing 12 citing articles:
The role of colchicine in the management of COVID-19: a Meta-analysis
Kholoud Elshiwy, Ghada Essam El-Din Amin, Mohamed Nazmy Farres, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Kholoud Elshiwy, Ghada Essam El-Din Amin, Mohamed Nazmy Farres, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Alkaloids Derived from Tyrosine: Phenethylisoquinoline (Colchicine)
Mihir Halder, Pijush Paul, Sumita Jha
Springer eBooks (2025), pp. 1-36
Closed Access
Mihir Halder, Pijush Paul, Sumita Jha
Springer eBooks (2025), pp. 1-36
Closed Access
Colchicine for the treatment of patients with COVID-19: an updated systematic review and meta-analysis of randomised controlled trials
Huzaifa Ahmad Cheema, Uzair Jafar, Abia Shahid, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e074373-e074373
Open Access | Times Cited: 4
Huzaifa Ahmad Cheema, Uzair Jafar, Abia Shahid, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e074373-e074373
Open Access | Times Cited: 4
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients
Natália B. do Amaral, Tamara Silva Rodrigues, Marcela C Giannini, et al.
Inflammation Research (2023) Vol. 72, Iss. 5, pp. 895-899
Open Access | Times Cited: 11
Natália B. do Amaral, Tamara Silva Rodrigues, Marcela C Giannini, et al.
Inflammation Research (2023) Vol. 72, Iss. 5, pp. 895-899
Open Access | Times Cited: 11
Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial
Alberto Cecconi, Pablo Martínez-Vives, Alberto Vera, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Alberto Cecconi, Pablo Martínez-Vives, Alberto Vera, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Host genetics and gut microbiota composition: Baseline gut microbiota composition as a possible prognostic factor for the severity of COVID-19 in patients with familial Mediterranean fever disease
Vardan Tsaturyan, Anahit Manvelyan, Marine Balayan, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Vardan Tsaturyan, Anahit Manvelyan, Marine Balayan, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Angiotensin converting enzyme 2 gene expression and markers of oxidative stress are correlated with disease severity in patients with COVID-19
Afraa S. H. Alobaidy, Mona Elhelaly, Maggie E. Amer, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 5827-5836
Open Access | Times Cited: 3
Afraa S. H. Alobaidy, Mona Elhelaly, Maggie E. Amer, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 5827-5836
Open Access | Times Cited: 3
Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses
Mohammed Danjuma, Rana Sayed, Maryam Aboughalia, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20155-e20155
Open Access | Times Cited: 2
Mohammed Danjuma, Rana Sayed, Maryam Aboughalia, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20155-e20155
Open Access | Times Cited: 2
Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
Mohammed Danjuma, Ridhima Kaul, Tamader Alyaarabi, et al.
European Journal of Internal Medicine (2023) Vol. 112, pp. 126-127
Open Access | Times Cited: 1
Mohammed Danjuma, Ridhima Kaul, Tamader Alyaarabi, et al.
European Journal of Internal Medicine (2023) Vol. 112, pp. 126-127
Open Access | Times Cited: 1
The Role of Colchicine in the Management of COVID-19: A Meta-analysis
Kholoud Elshiwy, Ghada Essam El-Din Amin, M. Nazmy, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Kholoud Elshiwy, Ghada Essam El-Din Amin, M. Nazmy, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities
José Hernández‐Rodríguez, Julio Durán-Sanclemente, Sergio Prieto‐González, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 11, pp. 949-964
Open Access | Times Cited: 2
José Hernández‐Rodríguez, Julio Durán-Sanclemente, Sergio Prieto‐González, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 11, pp. 949-964
Open Access | Times Cited: 2
Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
Josef Finsterer
Rheumatology and Therapy (2022) Vol. 9, Iss. 4, pp. 1229-1231
Open Access
Josef Finsterer
Rheumatology and Therapy (2022) Vol. 9, Iss. 4, pp. 1229-1231
Open Access
